Enclosed disclosure under Regulation 30 (LODR).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Sidde Gowda has resigned from the position of Vice President – Operations at Pharmaids Pharmaceuticals Limited, effective December 10, 2025. The resignation is due to personal reasons and pre-occupation, as stated in his resignation letter. The company has disclosed this under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, confirming no other material reasons for the departure. The resignation letter and required disclosure details have been submitted to BSE. This is a senior management-level exit and does not involve any board or KMP change.
The departure of a senior operations leader may cause short-term disruption in operations, but since the reason is personal and the exit is from a non-board, non-CXO role, the impact on shareholders or stock price is expected to be minimal.